Research Article

Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects

Figure 1

BAI attenuated T2DM-induced cardiac remodeling: (a) heart weight (HW)/tibia length (Tib), (b) HE staining of the left ventricle, (c) calculated cardiomyocyte surface area (CSA), and (d) the expression of cardiac remodeling-associated biomarkers, including ANP, BNP, and β-MHC. . T2DM: type 2 diabetes mellitus; VEH: vehicle; DM: diabetes mellitus; BAI: Bailcalin. compared with the VEH or BAI group; # compared with the DM group.